USC Norris Comprehensive Cancer Center to Open Radiation Oncology and Imaging Center in Newport Beach

The new location will feature new-to-market technology not yet available in Orange County

2024-08-07

(Press-News.org) LOS ANGELES — USC Norris Comprehensive Cancer Center, part of Keck Medicine of USC, will open a Newport Beach location offering the latest advancements in radiation therapy and diagnostic imaging. The treatment center, which will open in early 2025, will feature cutting-edge cancer technologies that are yet to be available in Orange County, providing new therapeutic options and optimizing patient outcomes.

The new location address is 4590 MacArthur Blvd. in Newport Beach, less than 15 minutes away from USC Norris’ oncology centers in Newport Beach and Irvine. Those centers are staffed by respected oncologists who have served Orange County for decades, and who treat more medical oncology outpatients in Newport Beach than any other providers.

“We are excited to build upon USC Norris’ well-established, robust cancer practices in Orange County and broaden our spectrum of services,” said Louis Vandermolen, MD, medical oncologist with USC Norris Oncology/Hematology. “Our radiation oncology and imaging center is a testament to our continued commitment to offer world class, comprehensive cancer services for patients without having to leave the local community.”

As one of the eight original National Cancer Institute-designated Comprehensive Cancer Centers in the United States, USC Norris has revolutionized cancer treatment, research and prevention for 50 years. In 2024-25, U.S. News & World Report ranked USC Norris Comprehensive Cancer Center among the top 25 cancer centers nationally and recognized USC Norris Cancer Hospital as a Best Specialty Hospital.

USC Norris is collaborating on their new Newport Beach facility with Advanced Radiotherapy Technologies (ART Health), a leading developer of radiotherapy centers. ART Health is a division of Kingsbarn Realty Capital, a national investment manager.

### 

For more information about Keck Medicine of USC, please visit news.KeckMedicine.org.

END

ELSE PRESS RELEASES FROM THIS DATE:

MD Anderson Research Highlights for August 7, 2024

2024-08-07

HOUSTON ― The University of Texas MD Anderson Cancer Center’s Research Highlights showcases the latest breakthroughs in cancer care, research and prevention. These advances are made possible through seamless collaboration between MD Anderson’s world-leading clinicians and scientists, bringing discoveries from the lab to the clinic and back. Recent developments at MD Anderson include insights into evolutionary cellular adaptations to environmental stressors, potential targets to overcome trouble swallowing in head and neck cancer patients treated with radiation therapy, a promising chemotherapy-free ...

Some e-cigarette chemicals mimic nicotine, possibly bypassing regulation

2024-08-07

DURHAM, N.C. – In what appears to be an effort to bypass public health regulations covering vaping products, some tobacco companies have begun replacing nicotine in e-cigarettes with related chemicals that have similar properties but unknown health effects, Duke Health researchers report. In a research letter appearing Aug. 7 in JAMA, study authors at Duke and Yale University also found that the quantity of these chemicals, known as nicotine analogs, are not accurately disclosed on the packaging. “Vaping products containing nicotine are subject to federal laws that prohibit sales to people under the age of 21,” said study co-author Sairam V. Jabba, ...

New 400-year temperature record shows Great Barrier Reef is facing catastrophic damage, researchers warn

2024-08-07

The Great Barrier Reef is under critical pressure, with warming sea temperatures and mass coral bleaching events threatening to destroy the remarkable ecology, biodiversity, and beauty of the world’s largest coral reef, according to new research published today. ‘Highest ocean heat in four centuries places Great Barrier Reef in danger’, published in Nature (8 August), led by University of Wollongong (UOW) Honorary Fellow and University of Melbourne Lecturer Dr Benjamin Henley, provides new evidence of the impact that rising sea surface temperatures ...

Corn’s ‘missing link’

2024-08-07

Cold Spring Harbor Laboratory (CSHL) has begun to unravel a mystery millennia in the making. Our story begins 9,000 years ago. It was then that maize was first domesticated in the Mexican lowlands. Some 5,000 years later, the crop crossed with a species from the Mexican highlands called teosinte mexicana. This resulted in cold adaptability. From here, corn spread across the continent, giving rise to the vegetable that is now such a big part of our diets. But how did it adapt so quickly? What biological mechanisms allowed the highland crop’s traits to take hold? Today, a potential answer emerges. CSHL Professor and HHMI Investigator Rob Martienssen had ...

Scientists uncover hidden forces causing continents to rise

2024-08-07

Scientists at the University of Southampton have answered one of the most puzzling questions in plate tectonics: how and why ‘stable’ parts of continents gradually rise to form some of the planet’s greatest topographic features. They have found that when tectonic plates break apart, powerful waves are triggered deep within the Earth that can cause continental surfaces to rise by over a kilometre. Their findings help resolve a long-standing mystery about the dynamic forces that shape and connect some of the Earth’s most ...

Variability in constituents of e-cigarette products containing nicotine analogues

2024-08-07

About The Study: Discrepancies were observed between labeled and measured concentrations of nicotine analogues in e-cigarettes and e-cigarette liquids marketed as nicotine replacements and exempt from FDA’s regulatory purview. Such discrepancies may lead to uncertainty about user exposure. When coupled with the largely unknown acute and chronic inhalation hazards and addictive potential of nicotine analogues, assessing product risk based on exposure becomes challenging from a clinical and regulatory standpoint. With e-cigarettes increasingly considered for smoking cessation, the advent of nicotine analogue–containing products with ...

A vaping cessation text message program for adolescent e-cigarette users

2024-08-07

About The Study: A tailored, interactive text message intervention increased self-reported vaping cessation rates among adolescents recruited via social media channels. Quote from corresponding author Amanda L. Graham, PhD: “Health care providers, teachers, and parents have been asking how to help teens quit vaping. This study is a critical breakthrough that demonstrates the power of a behavioral intervention for vaping cessation. Text messages serve as powerful reminders of an initial commitment to quit and can deliver proven behavior change support right to a young person’s phone. “We also did not see evidence that teens who quit ...

Neighborhood socioeconomic disadvantage across the life course and premature mortality

2024-08-07

About The Study: Low neighborhood socioeconomic status was associated with premature mortality in this study. The risk of premature mortality was greatest among individuals experiencing persistently low neighborhood socioeconomic status from young to middle adulthood. Place-based interventions that target neighborhood social determinants of health should be designed from a life course perspective that accounts for early-life socioeconomic inequality. Corresponding Author: To contact the corresponding author, Wayne R. Lawrence, DrPH, email wayne.lawrence@nih.gov. To access the embargoed ...

Cocaine discovery could pave way for treatment for substance abuse

2024-08-07

You have probably heard of dopamine. The substance also known as the “feel-good hormone”. Drugs such as cocaine cause a surge of dopamine in the brain. Normally, a protein in the brain called the dopamine transporter (DAT) helps regulate dopamine levels and prevent the brain from thinking that every experience is pleasurable. However, when affected by cocaine, the brain is unable to regulate dopamine levels. Previously, researchers did not know how cocaine affects the different transporters in the brain, but a new study from the University of Copenhagen has changed that. “We have learned how cocaine binds to the dopamine transporter, which is ...

Link discovered between sensory neurons and breast cancer metastasis

2024-08-07

Cancer doesn’t grow in a vacuum—each tumor grows in a particular microenvironment within the body and spreads through a tangled web of vasculature and nerves. Scientists have come to understand that the most potent therapies address cancer in context—accounting for both the tumor and the support structure that forms around it. Now, a new paper in Nature reveals that the activation of sensory nerves within breast tumors is playing a critical role in promoting not only cancer growth but also its spread, known as metastasis. The findings—that sensory neurons ...

LAST 30 PRESS RELEASES:

First-in-human trial shows promising results for DLL3-targeted antibody-drug conjugate SHR-4849 in relapsed small cell lung cancer

Ifinatamab deruxtecan demonstrates high response rate in previously treated extensive-stage small cell lung cancer: Phase 2 IDeate-Lung01 trial

Higher blood pressure in childhood linked to earlier death from heart disease in adulthood

AI helped older adults report accurate blood pressure readings at home

High blood pressure in childhood and premature cardiovascular disease mortality

Zidesamtinib shows durable responses in ROS1 TKI pre-treated NSCLC, including patients with CNS disease and ROS1 G2032R mutations

Crizotinib fails to improve disease-free survival in resected early-stage ALK+ NSCLC

Ivonescimab plus chemotherapy improves progression-free survival in patients with EGFR+ NSCLC following 3rd-generation EGFR-TKI therapy

FLAURA2 trial shows osimertinib plus chemotherapy improves overall survival in eGFR-mutated advanced NSCLC

Aumolertinib plus chemotherapy improves progression-free survival in NSCLC with EGFR and concomitant tumor suppressor genes: ACROSS 2 phase III study

New antibody-drug conjugate shows promising efficacy in EGFR-mutated NSCLC patients

Iza-Bren in combination with osimertinib shows 100% response rate in EGFR-mutated NSCLC, phase II study finds

COMPEL study shows continuing osimertinib treatment through progression with the addition of chemotherapy improves progression-free survival in EGFR-mutated NSCLC